SBIR Phase I: Multiplexed suspension array for rapid, point-of-care molecular diagnostics

这项小型企业创新研究（SBIR）第一阶段研究项目旨在开发一种基于微珠的悬浮阵列产品，用于分子诊断（基因筛选），可以在不需要样品扩增和荧光标记的情况下进行近实时的多路测量。这项技术可能对人类和动物的诊断市场产生直接的积极影响，并将使医疗保健提供者能够对患者的疾病概况和对不同治疗方式的潜在反应作出更有根据的评估。

This Small Business Innovation Research (SBIR) Phase I research project aims to develop a microbead-based suspension array product for molecular diagnostics (genetic screening) that can make multiplexed measurements in near-real-time without the need for sample amplification and fluorescent labeling.The technology could have a direct positive impact on the diagnostic market for both humans and animals and will enable healthcare providers to make more educated assessments of a patient's disease profile and potential responsiveness to different therapeutic modalities.